Lei Zheng
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced Solid Tumor, Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | 2026-01-01 |
| Active Not Recruiting | A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer Pancreatic Cancer | Phase 2 | 2023-11-08 |
| Completed | Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatme Resectable Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma | Phase 2 | 2019-06-04 |